The Therapeutic Goods Administration (TGA) has delayed an announcement on the down-scheduling of CBD until late-December.
A notice published on the TGA website this morning states a final decision on cannabidiol is now expected in late-December 2020.
When the TGA announced its interim decision on down-scheduling CBD in September, it said there would be another round of public consultations before a final decision was published in November.
UPDATE: TGA weighs further advice ahead of down-scheduling decision